Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease

doi:10.3748/wjg.v20.i48.18240

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6678)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

477

WORD

196

HTML

3888

Figures (1-3)

130

Tables (1-5)

113

Sum=4804

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1054

Download

820

Sum=1874

Dec 28, 2014 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2014; 20(48): 18240-18248
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18240

Open in New Tab Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curve showing the sensitivity and specificity of alpha-fetoprotein, cytokeratin and CD133. ROC: Receiver operating characteristic; AFP: Alpha-fetoprotein; CK: Cytokeratin.

Open in New Tab Full Size Figure Download Figure

Figure 2 Flow cytometry results for a case of hepatocellular carcinoma. Percentage of cells positive for A: Cytokeratin (CK)19; B: CD133; C: CD90. FITC: Fluorescein isothiocyanate.

Open in New Tab Full Size Figure Download Figure

Figure 3 Flow cytometry results for a case of chronic hepatitis. A: Forward of side scatter of cells; Percentage of cells from a patient with CH positive for B: CD90; and C: CD133; Percentage of cells from normal hepatic tissue positive for D: CD133; E: CD90. FITC: Fluorescein isothiocyanate; CH: Chronic hepatitis.

Citation: Bahnassy AA, Zekri ARN, El-Bastawisy A, Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AAS, El-Labbody SS. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease. World J Gastroenterol 2014; 20(48): 18240-18248
URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18240.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18240